Yajnavalka Banerjee

30PUBLICATIONS
62CO-AUTHORS
Molecular targetsHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 15, 2026
Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy.

|Aug 27, 2026
Physiological Lipid Palmitoylcarnitine Constrains Factor Xa Signalling Through PAR-2 to Attenuate ERK-Driven Inflammation and Preserve Mitochondrial Membrane Potential in Chondrocytes.

|Jan 28, 2026
Pharmacologic Modulation of the PAR-2-ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells.

Layla Amiri, Rajashree Patnaik, Riah Lee Varghese

|Jan 28, 2026
The Protective Role of Curcumin in Osteoarthritis: Establishing Mitochondrial Homeostasis Through Autophagy Induction and Apoptosis Inhibition.

Kavitha Raja, Rajashree Patnaik, Dineshwary Suresh

|Nov 13, 2025
Epigallocatechin Gallate as a Molecular Therapeutic in Heart Failure and Cardio-Oncology: Mechanistic Pathways and Translational Perspectives.

Faika Ajaz, Jewel Haddad, Bintul Huda

|Sep 26, 2025
Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells.

Rajashree Patnaik, Riah Varghese, Ahad Al-Kabani

Pageof 5

Frequent Collaborators

8 joint publications

Manfredi Rizzo

7 joint publications

Rajashree Patnaik

6 joint publications

Anca Pantea Stoian

5 joint publications

Bintul Huda